Home  >  Products  >  THPO (thrombopoietin (myeloproliferative leukemia virus oncogene ligand, megakaryocyte growth and development factor)) Blocking Peptide (the middle region of protein) (100ug)
THPO (thrombopoietin (myeloproliferative leukemia virus oncogene ligand, megakaryocyte growth and development factor)) Blocking Peptide (the middle region of protein) (100ug)

THPO (thrombopoietin (myeloproliferative leukemia virus oncogene ligand, megakaryocyte growth and development factor)) Blocking Peptide (the middle region of protein) (100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-THPO antibody (Catalogue #: ARP58735_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP58735
Size: 100 ug
Weight: 35kDa
Gene: 7066
Format: Lyophilized powder
Target: Megakaryocytopoiesis is the cellular development process that leads to platelet production. THPO is a humoral growth factor that is necessary for megakaryocyte proliferation and maturation, as well as for thrombopoiesis. THPO is the ligand for MLP/C_MPL, the product of myeloproliferative leukemia virus oncogene.Megakaryocytopoiesis is the cellular development process that leads to platelet production. The protein encoded by this gene is a humoral growth factor that is necessary for megakaryocyte proliferation and maturation, as well as for thrombopoiesis. This protein is the ligand for MLP/C_MPL, the product of myeloproliferative leukemia virus oncogene. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Alternative names: MGC163194; MGDF; MKCSF; ML; MPLLG; TPO